LTRN
USDLantern Pharma Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$3.260
Максимум
$3.510
Минимум
$3.020
Объем
0.09M
Фундаментальные показатели компании
Рыночная капитализация
36.9M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
0.13M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, will both be
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific antibody therapies, validating LP-284's mechanism of action. A novel differentiated
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today
Связанные акции
OXLCN
Oxford Lane Capital Corp. 7.125% Series 2029 Term Preferred Stock
PFLT
PennantPark Floating Rate Capital Ltd.
SVIIW
Spring Valley Acquisition Corp. II Warrant
AOGOU
Arogo Capital Acquisition Corp. Unit
UEIC
Universal Electronics Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.